Literature DB >> 30336471

The Validity of the Norwegian Version of the Cognitive Function Instrument.

Mona Michelet1,2,3, Knut Engedal4,5, Geir Selbæk4,6,7, Anne Lund8, Guro Hanevold Bjørkløf4, Peter Otto Horndalsveen9, Sverre Bergh4,7.   

Abstract

BACKGROUND/AIMS: A timely diagnosis of dementia is important, and the Cognitive Function Instrument (CFI) is a newly developed instrument to screen for cognitive decline. The aim of this study was to evaluate the validity and internal consistency of the Norwegian version of the CFI.
METHODS: We included 265 participants with dementia, mild cognitive impairment (MCI), subjective cognitive impairment (SCI), and a reference group without subjective or assessed cognitive decline. The participants and their relatives answered the self- and proxy-rated versions of the CFI.
RESULTS: The Norwegian CFI had power to discriminate between people with dementia and with MCI, SCI, and the reference group. The proxy version had better power than the self-rated version in our participants (area under the curve [AUC] proxy-rated varying from 0.79 to 0.99, AUC self-rated varying from 0.56 to 0.85).
CONCLUSION: The Norwegian CFI was found to be a useful, valid, and robust instrument.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Activities of daily living; Cognition; Dementia; Mild cognitive impairment; Screening

Mesh:

Year:  2018        PMID: 30336471     DOI: 10.1159/000493463

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  3 in total

1.  Translation, cross-cultural adaptation, and validity of the Brazilian version of the Cognitive Function Instrument.

Authors:  Adalberto Studart-Neto; Natália Cristina Moraes; Raphael Ribeiro Spera; Silvia Stahl Merlin; Jacy Bezerra Parmera; Omar Jaluul; Mônica SanchesYassuda; Sonia Maria Dozzi Brucki; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2022 Jan-Mar

2.  Validity and reliability of the Farsi version of the ascertain dementia 8-item (AD8-F) informant interview in Iranian patients with mild neurocognitive disorder.

Authors:  Maryam Pourshams; James E Galvin; Pouya Farokhnezhad Afshar; Pamela Gail Santos; Shahrzad Bazargan-Hejazi; Leila Kamalzadeh; Behnam Shariati; Seyed Kazem Malakouti
Journal:  BMC Geriatr       Date:  2022-10-14       Impact factor: 4.070

3.  Validation of the Brief Assessment of Impaired Cognition and the Brief Assessment of Impaired Cognition Questionnaire for identification of mild cognitive impairment in a memory clinic setting.

Authors:  Kasper Jørgensen; Thomas R Nielsen; Ann Nielsen; Frans B Waldorff; Gunhild Waldemar
Journal:  Int J Geriatr Psychiatry       Date:  2020-04-26       Impact factor: 3.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.